Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406
Changes in Abstract
Changes in Materials and Methods
Changes in Results
3. Results
3.1. Subjects Characteristics
3.2. Microbiota Measures
3.2.1. Taxonomic Composition Analysis and Associations with Symptoms
3.2.2. Effect of Medication on the Regression Results and on Gut Microbiota Composition
Changes in Discussion
4. Discussion
Change in Supplementary Materials
Change in Author Names (Add a New One)
Author Contributions
Funding
Conflicts of Interest
References
- Szopinska-Tokov, J.; Dam, S.; Naaijen, J.; Konstanti, P.; Rommelse, N.; Belzer, C.; Buitelaar, J.; Franke, B.; Aarts, E.; Vasquez, A.A. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406. [Google Scholar] [CrossRef] [Green Version]
- Anderson, M.J.; Ellingsen, K.E.; McArdle, B.H. Multivariate dispersion as a measure of beta diversity. Ecol. Lett. 2006, 9, 683–693. [Google Scholar] [CrossRef]
- D’Argenio, V.; Salvatore, F. The role of the gut microbiome in the healthy adult status. Clin. Chim. Acta 2015, 451, 97–102. [Google Scholar] [CrossRef] [Green Version]
- Prehn-Kristensen, A.; Zimmermann, A.; Tittmann, L.; Lieb, W.; Schreiber, S.; Baving, L.; Fischer, A. Reduced microbiome alpha diversity in young patients with ADHD. PLoS ONE 2018, 13, e0200728. [Google Scholar] [CrossRef]
- Jiang, H.-Y.; Zhou, Y.-Y.; Zhou, G.-L.; Li, Y.-C.; Yuan, J.; Li, X.-H.; Ruan, B. Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder. Behav. Brain Res. 2018, 347, 408–413. [Google Scholar] [CrossRef]
- Aarts, E.; Ederveen, T.; Naaijen, J.; Zwiers, M.P.; Boekhorst, J.; Timmerman, H.M.; Smeekens, S.P.; Netea, M.G.; Buitelaar, J.K.; Franke, B.; et al. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS ONE 2017, 12, e0183509. [Google Scholar] [CrossRef] [PubMed]
- Akram, H. Characterizing a Link between Gut Microbiome and Attention Deficit Hyperactive Disorder. Honors College Research Collection. 2017. Available online: https://digitalcommons.fiu.edu/honors-research/4 (accessed on 5 June 2021).
- Wang, L.-J.; Yang, C.-Y.; Chou, W.-J.; Lee, M.-J.; Chou, M.-C.; Kuo, H.-C.; Yeh, Y.-M.; Lee, S.-Y.; Huang, L.-H.; Li, S.-C. Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. Eur. Child. Adolesc. Psychiatry 2019, 29, 287–297. [Google Scholar] [CrossRef] [PubMed]
- Tengeler, A.C.; Dam, S.A.; Wiesmann, M.; Naaijen, J.; Van Bodegom, M.; Belzer, C.; Dederen, P.J.; Verweij, V.; Franke, B.; Kozicz, T.; et al. Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice. Microbiome 2020, 8, 1–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koh, A.; De Vadder, F.; Kovatcheva-Datchary, P.; Bäckhed, F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell 2016, 165, 1332–1345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- den Besten, G.; van Eunen, K.; Groen, A.K.; Venema, K.; Reijngoud, D.J.; Bakker, B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325–2340. [Google Scholar] [CrossRef] [Green Version]
- Dam, S.A.; Mostert, J.C.; Szopinska-Tokov, J.W.; Bloemendaal, M.; Amato, M.; Arias-Vasquez, A. The Role of the Gut-Brain Axis in Attention-Deficit/Hyperactivity Disorder. Gastroenterol. Clin. N. Am. 2019, 48, 407–431. [Google Scholar] [CrossRef] [PubMed]
- Wang, L.; Christophersen, C.T.; Sorich, M.J.; Gerber, J.P.; Angley, M.T.; Conlon, M.A. Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder. Dig. Dis. Sci. 2012, 57, 2096–2102. [Google Scholar] [CrossRef] [PubMed]
- Abdelli, L.S.; Samsam, A.; Naser, S.A. Propionic Acid Induces Gliosis and Neuro-inflammation through Modulation of PTEN/AKT Pathway in Autism Spectrum Disorder. Sci. Rep. 2019, 9, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gerritsen, J.; Fuentes, S.; Grievink, W.; Van Niftrik, L.; Tindall, B.J.; Timmerman, H.M.; Rijkers, G.T.; Smidt, H. Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov. Int. J. Syst. Evol. Microbiol. 2014, 64, 1600–1616. [Google Scholar] [CrossRef]
- Forslund, K.; Hildebrand, F.; Nielsen, T.R.; Falony, G.; Le Chatelier, E.; Sunagawa, S.; Prifti, E.; Vieira-Silva, S.; Gudmundsdottir, V.; Pedersen, H.K.; et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015, 528, 262–266. [Google Scholar] [CrossRef]
- Paone, P.; Cani, P.D. Mucus barrier, mucins and gut microbiota: The expected slimy partners? Gut 2020, 69, 2232–2243. [Google Scholar] [CrossRef] [PubMed]
- Wasilewska, J.J.; Klukowski, M. Gastrointestinal symptoms and autism spectrum disorder: Links and risks—A possible new overlap syndrome. Pediatr. Health Med. Ther. 2015, 6, 153–166. [Google Scholar] [CrossRef] [Green Version]
- Chen, M.H.; Su, T.P.; Chen, Y.S.; Hsu, J.W.; Huang, K.L.; Chang, W.H.; Bai, Y.M. Comorbidity of Allergic and Autoimmune Diseases among Patients with ADHD: A Nationwide Population-Based Study. J. Atten. Disord. 2017, 21, 219–227. [Google Scholar] [CrossRef]
- Szopinska, J.W.; Gresse, R.; Van Der Marel, S.; Boekhorst, J.; Lukovac, S.; Van Swam, I.; Franke, B.; Timmerman, H.; Belzer, C.; Vasquez, A.A. Reliability of a participant-friendly fecal collection method for microbiome analyses: A step towards large sample size investigation. BMC Microbiol. 2018, 18, 1–11. [Google Scholar] [CrossRef]
- Rintala, A.; Pietilä, S.; Munukka, E.; Eerola, E.; Pursiheimo, J.-P.; Laiho, A.; Pekkala, S.; Huovinen, P. Gut Microbiota Analysis Results Are Highly Dependent on the 16S rRNA Gene Target Region, Whereas the Impact of DNA Extraction Is Minor. J. Biomol. Tech. 2017, 28, 19–30. [Google Scholar] [CrossRef]
- Allali, I.; Arnold, J.W.; Roach, J.; Cadenas, M.B.; Butz, N.; Hassan, H.M.; Koci, M.; Ballou, A.; Mendoza, M.; Ali, R.; et al. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome. BMC Microbiol. 2017, 17, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Cussotto, S.; Strain, C.R.; Fouhy, F.; Strain, R.G.; Peterson, V.L.; Clarke, G.; Stanton, C.; Dinan, T.G.; Cryan, J.F. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology 2019, 236, 1671–1685. [Google Scholar] [CrossRef] [PubMed]
ADHD | Control | Subthreshold ADHD | p-Value a | |
---|---|---|---|---|
N | 41 | 48 | 14 | - |
Age, mean (SD) | 20.2 (4.1) | 20.4 (3.5) | 20.3 (3.4) | NS |
Age, range | 13–29 | 13–28 | 14–26 | - |
BMI, median (IQR) | 23 (20.5–25.5) | 22 (20–23) | 22 (20–23) | NS |
BMI, range | 16–31 | 16–31 | 20–30 | - |
BMI ≥ 25, % | 29 | 19 | 14 | NS |
Male, % | 61 | 50 | 36 | NS |
Use of ADHD medication, N | 19 | 0 | 3 | - |
Diff_days, median (IQR) | 17 (14–34) | 32 (13–64) | 14.5 (10.5–30) | NS |
Conners’ | ||||
Inattention, median (IQR) | 64 (58–76) | 42 (38–53) | 57 (52–64) | <0.001 |
Hyperactivity/Impulsivity, median (IQR) | 56.5 (50–64.5) | 41 (36–49) | 57 (50–64) | <0.001 |
Variable | N | R2 | Pseudo-F | p-Value |
---|---|---|---|---|
Disorder status | 89 | 0.009 | 0.79 | 0.479 |
Age | 103 | 0.005 | 0.55 | 0.727 |
Sex | 103 | 0.005 | 0.54 | 0.750 |
BMI | 98 | 0.005 | 0.46 | 0.874 |
IA | 102 | 0.009 | 0.95 | 0.360 |
HI | 102 | 0.010 | 1.04 | 0.322 |
medication | 41 | 0.021 | 0.84 | 0.469 |
Inattention | Hyperactivity/Impulsivity | |||||||
---|---|---|---|---|---|---|---|---|
N | B (S.E.) a | 95% CI | p-Value | N | B (S.E.) a | 95% CI | p-Value | |
Prevotella_9 | 98 | 0.111 (0.099) | −0.079–0.306 | 0.267 | 98 | 0.118 (0.096) | −0.065–0.308 | 0.222 |
Coprococcus_2 | 95 | −3.189 (1.639) | −6.325–(−0.029) | 0.055 | 96 | −2.331 (1.456) | −5.108–0.492 | 0.113 |
Intestinibacter | 85 | 191.161 (139.654) | −74.119–4.587 | 0.175 | 94 | 33.829 (22.779) | −9.855–77.482 | 0.141 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Szopinska-Tokov, J.; Dam, S.; Naaijen, J.; Konstanti, P.; Rommelse, N.; Belzer, C.; Buitelaar, J.; Franke, B.; Bloemendaal, M.; Aarts, E.; et al. Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406. Microorganisms 2021, 9, 1358. https://doi.org/10.3390/microorganisms9071358
Szopinska-Tokov J, Dam S, Naaijen J, Konstanti P, Rommelse N, Belzer C, Buitelaar J, Franke B, Bloemendaal M, Aarts E, et al. Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406. Microorganisms. 2021; 9(7):1358. https://doi.org/10.3390/microorganisms9071358
Chicago/Turabian StyleSzopinska-Tokov, Joanna, Sarita Dam, Jilly Naaijen, Prokopis Konstanti, Nanda Rommelse, Clara Belzer, Jan Buitelaar, Barbara Franke, Mirjam Bloemendaal, Esther Aarts, and et al. 2021. "Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. Microorganisms 2020, 8, 406" Microorganisms 9, no. 7: 1358. https://doi.org/10.3390/microorganisms9071358